Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms by Site × Dasatinib × 90 days × Clear all

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4 Burkitt Lymphoma 4 Leukemia, Myeloid, Chronic-Phase 3 Leukemia 3 Philadelphia Chromosome 2 Neoplasms 2 Leukemia, Myeloid, Acute 2 Primary Myelofibrosis 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Polycythemia Vera 1 Pancreatic Neoplasms 1 Neuroblastoma 1 Neoplasm, Residual 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Mastocytosis 1 Lymphoma, Non-Hodgkin 1 Lymphoma 1 Leukemia, Prolymphocytic 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia, Biphenotypic, Acute 1 Hypereosinophilic Syndrome 1 Glioma 1 Frailty 1 Brain Neoplasms 1 Blast Crisis 1

Interventions

durvalumab 3 Fulvestrant 3 Cisplatin 3 Carboplatin 3 ribociclib 2 pembrolizumab 2 palbociclib 2 abemaciclib 2 Pemetrexed 2 Letrozole 2 Anastrozole 2 trametinib 1 taletrectinib 1 sotorasib 1 selpercatinib 1 relatlimab 1 pralsetinib 1 exemestane 1 elacestrant 1 darolutamide 1 dabrafenib 1 ceralasertib 1 Watchful Waiting 1 Transurethral Resection of Prostate 1 Sunitinib 1 STX-478 1 Radiotherapy, Intensity-Modulated 1 Radiosurgery 1 RAD1901 1 Pregnancy Tests 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡